1. Ampelopsin Inhibits Breast Cancer Cell Growth through Mitochondrial Apoptosis Pathway
   Yue Li et al, 2021, Biological and Pharmaceutical Bulletin CrossRef
2. Fangchinoline inhibits the PEDV replication in intestinal epithelial cells via autophagic flux suppression
   Weixiao Zhang et al, 2023, Frontiers in Microbiology CrossRef
3. Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models
   Myriam Mérarchi et al, 2018, Molecules CrossRef
4. Fangchinoline Inhibits Human Esophageal Cancer by Transactivating ATF4 to Trigger Both Noxa-Dependent Intrinsic and DR5-Dependent Extrinsic Apoptosis
   Yunjing Zhang et al, 2021, Frontiers in Oncology CrossRef
5. Ampelopsin E Reduces the Invasiveness of the Triple Negative Breast Cancer Cell Line, MDA-MB-231
   Francis Yew Fu Tieng et al, 2019, Molecules CrossRef
6. Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways
   Young Yun Jung et al, 2019, Molecules CrossRef
7. Ampelopsin Inhibits Breast Cancer Glucose Metabolism Reprogramming Based on Network Pharmacology and Molecular Docking
   Rong Zeng et al, 2022, Oncologie CrossRef
8. Fangchinoline Has an Anti-Arthritic Effect in Two Animal Models and in IL-1β-Stimulated Human FLS Cells
   Thea Villa et al, 2020, Biomolecules & Therapeutics CrossRef